Back to Show
PBS News Hour
What’s keeping biosimilar drugs from the U.S. market?
NewsHour looks at a revolutionary class of drugs called "biologics." Americans have been paying more for their benefits than patients in Europe or Asia some say, because the "generic" versions or "biosimilars" have not hit the U.S. market. Dr. Emily Senay looks into why there's a delay and when American consumers can expect discounts.
Support Provided By
26:45
September 6, 2025 - PBS News Weekend full episode

57:46
September 5, 2025 - PBS News Hour full episode

57:46
September 4, 2025 - PBS News Hour full episode

57:46
September 3, 2025 - PBS News Hour full episode

57:46
September 2, 2025 - PBS News Hour full episode

57:46
September 1, 2025 - PBS News Hour full episode

26:45
August 31, 2025 - PBS News Weekend full episode

26:45
August 30, 2025 - PBS News Weekend full episode

57:46
August 29, 2025 - PBS News Hour full episode

57:46
August 28, 2025 - PBS News Hour full episode

57:46
August 27, 2025 - PBS News Hour full episode

57:46
August 26, 2025 - PBS News Hour full episode